Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure
- PMID: 6085239
- DOI: 10.3109/13813458409071161
Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure
Abstract
The haemodynamic effects of an optimal dose of dobutamine (DUo) (6.7 +/- 4.2 micrograms kg-1 min-1) and the combination of this optimal dose minus 2.5 micrograms kg-1 min-1 of dobutamine (DU) plus dopamine 2.5 micrograms kg-1 min-1 (DA) were studied in a first group of 12 consecutive patients with acute myocardial infarction (AMI) and cardiac failure (CF). DUo decreased pulmonary wedge pressure from 23.5 to 16 mm Hg (P less than 0.01), systemic vascular resistance from 1 774 to 1 417 dynes s cm-5 (P less than 0.01). DUo increased cardiac output from 3.21 to 4.55 litres/min (P less than 0.01) and urinary flow (UF) from 20 to 68 ml/h (P less than 0.01). Heart rate and blood pressure did not change significantly. DUo - DU + DA significantly increased UF from 68 to 107 ml/h (P less than 0.05) while the other parameters remained unchanged with respect to DUo. The positive effect of DA on UF was confirmed in a second group of 12 consecutive patients by comparing the successive effects of DA + DUo and DUo + DU : all previously described parameters remained unchanged except UF which decreased from 107 to 65 (P less than 0.01). We conclude that in patients with CF and AMI, association of DA and DUo is useful in obtaining both inotropic and diuretic effects.
Similar articles
-
Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.Gerontology. 1984;30(6):408-13. doi: 10.1159/000212665. Gerontology. 1984. PMID: 6519441
-
Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse.Am Heart J. 1982 Jun;103(6):995-1000. doi: 10.1016/0002-8703(82)90562-2. Am Heart J. 1982. PMID: 7081040 Clinical Trial.
-
Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.Circulation. 1977 Feb;55(2):375-8. doi: 10.1161/01.cir.55.2.375. Circulation. 1977. PMID: 318933 Clinical Trial.
-
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].Dtsch Med Wochenschr. 1985 Apr 12;110(15):598-603. doi: 10.1055/s-2008-1068872. Dtsch Med Wochenschr. 1985. PMID: 2983969 Review. German. No abstract available.
-
Dobutamine in heart failure.Eur Heart J. 1982 Dec;3 Suppl D:107-14. Eur Heart J. 1982. PMID: 6761125 Review. No abstract available.
Cited by
-
Inotropic support of the critically ill patient. A review of the agents.Drugs. 1993 May;45(5):654-67. doi: 10.2165/00003495-199345050-00003. Drugs. 1993. PMID: 7686461 Review.
-
Inotropic Agents: Are We Still in the Middle of Nowhere?J Clin Med. 2024 Jun 26;13(13):3735. doi: 10.3390/jcm13133735. J Clin Med. 2024. PMID: 38999301 Free PMC article. Review.
-
New dopamine receptor agonists in heart failure and hypertension. Implications for future therapy.Drugs. 1990 Oct;40(4):487-92. doi: 10.2165/00003495-199040040-00001. Drugs. 1990. PMID: 1982088 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous